SP100 | SP100 nuclear antigen | 2q37.1 | 0.798 | 0.866 | 0
|
UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 11q12.1 | 0.618 | 0.776 | 0
|
IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 10q23.31 | 0.6 | 0.769 | 0
|
PSMB9 | proteasome subunit beta 9 | 6p21.3 | 0.594 | 0.768 | 0
|
IFIH1 | interferon induced with helicase C domain 1 | 2q24.2 | 0.591 | 0.765 | 0
|
SAMD9L | sterile alpha motif domain containing 9-like | 7q21.2 | 0.588 | 0.768 | 0
|
IFI35 | interferon-induced protein 35 | 17q21 | 0.575 | 0.758 | 0
|
TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 6p21.3 | 0.566 | 0.701 | 0
|
TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 6p21.3 | 0.562 | 0.715 | 0
|
STAT1 | signal transducer and activator of transcription 1, 91kDa | 2q32.2-q32.3 | 0.559 | 0.748 | 0
|
DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | 4q32.3 | 0.553 | 0.714 | 0
|
DTX3L | deltex 3 like, E3 ubiquitin ligase | 3q21.1 | 0.551 | 0.636 | 0
|
B2M | beta-2-microglobulin | 15q21.1 | 0.549 | 0.738 | 0
|
IFI44L | interferon-induced protein 44-like | 1p22.3 | 0.549 | 0.743 | 0
|
GBP1 | guanylate binding protein 1, interferon-inducible | 1p22.2 | 0.544 | 0.699 | 0
|
TRIM22 | tripartite motif containing 22 | 11p15 | 0.543 | 0.738 | 0
|
IFI44 | interferon-induced protein 44 | 1p31.1 | 0.539 | 0.738 | 0
|
DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 9p12 | 0.538 | 0.725 | 0
|
TYMP | thymidine phosphorylase | 22q13 | 0.537 | 0.691 | 0
|
HERC6 | HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 | 4q22 | 0.531 | 0.723 | 0
|
ZBP1 | Z-DNA binding protein 1 | 20q13.31 | 0.527 | 0.671 | 0
|
HLA-F | major histocompatibility complex, class I, F | 6p21.3 | 0.527 | 0.719 | 0
|
IFITM1 | interferon induced transmembrane protein 1 | 11p15.5 | 0.521 | 0.703 | 0
|
IRF1 | interferon regulatory factor 1 | 5q23-q31 | 0.521 | 0.668 | 0
|
HLA-B | major histocompatibility complex, class I, B | 6p21.3 | 0.513 | 0.694 | 0
|
XAF1 | XIAP associated factor 1 | 17p13.2 | 0.513 | 0.697 | 0
|
CASP1 | caspase 1, apoptosis-related cysteine peptidase | 11q23 | 0.512 | 0.727 | 0
|
APOL3 | apolipoprotein L, 3 | 22q13.1 | 0.512 | 0.697 | 0
|
BATF2 | basic leucine zipper transcription factor, ATF-like 2 | 11q13.1 | 0.512 | 0.702 | 0
|
PSMB8 | proteasome subunit beta 8 | 6p21.3 | 0.51 | 0.714 | 0
|
HLA-E | major histocompatibility complex, class I, E | 6p21.3 | 0.506 | 0.711 | 0
|
IFIT5 | interferon-induced protein with tetratricopeptide repeats 5 | 10q23.31 | 0.504 | 0.686 | 0
|
PARP12 | poly (ADP-ribose) polymerase family, member 12 | 7q34 | 0.502 | 0.698 | 0
|
BTN3A3 | butyrophilin, subfamily 3, member A3 | 6p22.1 | 0.501 | 0.672 | 0
|
HLA-H | major histocompatibility complex, class I, H (pseudogene) | 6p21.3 | 0.499 | 0.68 | 0
|
SP140 | SP140 nuclear body protein | 2q37.1 | 0.498 | 0.687 | 0
|
ISG20 | interferon stimulated exonuclease gene 20kDa | 15q26 | 0.495 | 0.676 | 0
|
IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | 10q23.31 | 0.495 | 0.672 | 0
|
IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 | 10q23.31 | 0.492 | 0.688 | 0
|
OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 12q24.2 | 0.49 | 0.687 | 0
|
TRIM21 | tripartite motif containing 21 | 11p15.5-p15.3 | 0.486 | 0.738 | 0
|
CARD16 | caspase recruitment domain family, member 16 | 11q23 | 0.486 | 0.7 | 0
|
MX1 | MX dynamin-like GTPase 1 | 21q22.3 | 0.485 | 0.669 | 0
|
IL15RA | interleukin 15 receptor, alpha | 10p15.1 | 0.476 | 0.666 | 0
|
IL15 | interleukin 15 | 4q31 | 0.472 | 0.673 | 0
|
IFI6 | interferon, alpha-inducible protein 6 | 1p35 | 0.47 | 0.634 | 0
|
HLA-A | major histocompatibility complex, class I, A | 6p21.3 | 0.467 | 0.687 | 0
|
ODF3B | outer dense fiber of sperm tails 3B | 22q13.33 | 0.466 | 0.667 | 0
|
NMI | N-myc (and STAT) interactor | 2q23 | 0.463 | 0.654 | 0
|
IFITM3 | interferon induced transmembrane protein 3 | 11p15.5 | 0.463 | 0.664 | 0
|
RSAD2 | radical S-adenosyl methionine domain containing 2 | 2p25.2 | 0.462 | 0.639 | 0
|
PML | promyelocytic leukemia | 15q24.1 | 0.453 | 0.619 | 0
|
SAMD9 | sterile alpha motif domain containing 9 | 7q21.2 | 0.439 | 0.659 | 0
|
CMPK2 | cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial | 2p25.2 | 0.438 | 0.574 | 0
|
AIM2 | absent in melanoma 2 | 1q22 | 0.437 | 0.606 | 0
|
IFI27 | interferon, alpha-inducible protein 27 | 14q32.12 | 0.435 | 0.633 | 0
|
DDX60L | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like | 4q32.3 | 0.434 | 0.618 | 0
|
IRF9 | interferon regulatory factor 9 | 14q11.2 | 0.434 | 0.648 | 0
|
CCL3 | chemokine (C-C motif) ligand 3 | 17q12 | 0.433 | 0.56 | 0
|
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 22q13.1 | 0.427 | 0.589 | 0
|
PSME2 | proteasome activator subunit 2 | 14q11.2 | 0.424 | 0.604 | 0
|
OPTN | optineurin | 10p14 | 0.416 | 0.58 | 0
|
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 11q22.2-q22.3 | 0.415 | 0.623 | 0
|
IRF7 | interferon regulatory factor 7 | 11p15.5 | 0.409 | 0.546 | 0
|
CASP5 | caspase 5, apoptosis-related cysteine peptidase | 11q22.2-q22.3 | 0.403 | 0.55 | 0
|
BST2 | bone marrow stromal cell antigen 2 | 19p13.2 | 0.399 | 0.635 | 0
|
MLKL | mixed lineage kinase domain-like | 16q22.3 | 0.389 | 0.621 | 0
|
TMEM173 | transmembrane protein 173 | 5q31.2 | 0.388 | 0.575 | 0
|
MT2A | metallothionein 2A | 16q13 | 0.386 | 0.54 | 0
|
KSR2 | kinase suppressor of ras 2 | 12q24.22-q24.23 | 0.385 | -0.575 | 0
|
DANCR | differentiation antagonizing non-protein coding RNA | 4q12 | 0.384 | -0.572 | 0
|
TLR2 | toll-like receptor 2 | 4q32 | 0.381 | 0.603 | 0
|
PLSCR1 | phospholipid scramblase 1 | 3q23 | 0.381 | 0.555 | 0
|
PSME1 | proteasome activator subunit 1 | 14q11.2 | 0.38 | 0.557 | 0
|
FAM221A | family with sequence similarity 221, member A | 7p15.3 | 0.378 | -0.507 | 0
|
OASL | 2'-5'-oligoadenylate synthetase-like | 12q24.2 | 0.376 | 0.588 | 0
|
OTUD3 | OTU deubiquitinase 3 | 1p36.13 | 0.375 | -0.583 | 0
|
CD68 | CD68 molecule | 17p13 | 0.375 | 0.581 | 0
|
SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 5p15.2 | 0.374 | -0.441 | 0
|
ZNFX1 | zinc finger, NFX1-type containing 1 | 20q13.13 | 0.374 | 0.624 | 0
|
C3 | complement component 3 | 19p13.3-p13.2 | 0.374 | 0.496 | 0
|
IFI16 | interferon, gamma-inducible protein 16 | 1q22 | 0.367 | 0.602 | 0
|
PPP1R18 | protein phosphatase 1, regulatory subunit 18 | 6p21.3 | 0.367 | 0.505 | 0
|
HELZ2 | helicase with zinc finger 2, transcriptional coactivator | 20q13.33 | 0.362 | 0.539 | 0
|
ZNF711 | zinc finger protein 711 | Xq21.1 | 0.353 | -0.464 | 0
|
HPS5 | Hermansky-Pudlak syndrome 5 | 11p14 | 0.349 | 0.527 | 0
|
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 3q26 | 0.348 | 0.532 | 0
|
SLC9A2 | solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | 2q11.2 | 0.346 | -0.52 | 0
|
THRB | thyroid hormone receptor, beta | 3p24.2 | 0.345 | -0.442 | 0
|
CRHR1-IT1 | CRHR1 intronic transcript 1 | 17q21.31 | 0.345 | -0.512 | 0
|
CFLAR | CASP8 and FADD-like apoptosis regulator | 2q33-q34 | 0.345 | 0.566 | 0
|
ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa | 7q22.1 | 0.341 | 0.489 | 0
|
MEX3A | mex-3 RNA binding family member A | 1q22 | 0.341 | -0.468 | 0
|
LY6E | lymphocyte antigen 6 complex, locus E | 8q24.3 | 0.34 | 0.538 | 0
|
PDIK1L | PDLIM1 interacting kinase 1 like | 1p35.1 | 0.34 | -0.48 | 0
|
STK17A | serine/threonine kinase 17a | 7p13 | 0.339 | 0.502 | 0
|
UBE2F | ubiquitin-conjugating enzyme E2F (putative) | 2q37.3 | 0.339 | 0.566 | 0
|
RRAS | related RAS viral (r-ras) oncogene homolog | 19q13.33 | 0.338 | 0.508 | 0
|
FAM227A | family with sequence similarity 227, member A | 22q13.1 | 0.338 | -0.482 | 0
|
TNIP1 | TNFAIP3 interacting protein 1 | 5q32-q33.1 | 0.338 | 0.472 | 0
|
ACTR3 | ARP3 actin-related protein 3 homolog (yeast) | 2q14.1 | 0.337 | 0.424 | 0
|
MVP | major vault protein | 16p11.2 | 0.336 | 0.463 | 0
|
GNL3 | guanine nucleotide binding protein-like 3 (nucleolar) | 3p21.1 | 0.336 | -0.43 | 0
|
IFI27L2 | interferon, alpha-inducible protein 27-like 2 | 14q32.13 | 0.331 | 0.542 | 0
|
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 20q13.1 | 0.33 | 0.522 | 0
|
ACSM6 | acyl-CoA synthetase medium-chain family member 6 | 10q23.33 | 0.326 | -0.429 | 0
|
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | 3q29 | 0.326 | -0.46 | 0
|
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 16q22.1 | 0.325 | 0.34 | 6.46e-13
|
ACY3 | aminoacylase 3 | 11q13.2 | 0.32 | 0.51 | 0
|
GSDMC | gasdermin C | 8q24.21 | 0.319 | 0.456 | 0
|
SQRDL | sulfide quinone reductase-like (yeast) | 15q21.1 | 0.319 | 0.488 | 0
|
COPS8 | COP9 signalosome subunit 8 | 2q37.3 | 0.318 | 0.442 | 0
|
SCO2 | SCO2 cytochrome c oxidase assembly protein | 22q13.33 | 0.318 | 0.462 | 0
|
CD82 | CD82 molecule | 11p11.2 | 0.317 | 0.526 | 0
|
GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | 17q23.2 | 0.317 | -0.432 | 0
|
SAA2 | serum amyloid A2 | 11p15.1-p14 | 0.317 | 0.496 | 0
|
SP140L | SP140 nuclear body protein-like | 2q37.1 | 0.316 | 0.545 | 0
|
PANX1 | pannexin 1 | 11q14-q21 | 0.316 | 0.444 | 0
|
CAB39 | calcium binding protein 39 | 2q37.1 | 0.316 | 0.493 | 0
|
CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 | 19p13.12 | 0.315 | -0.4 | 0
|
ACVR2B | activin A receptor, type IIB | 3p22 | 0.314 | -0.499 | 0
|
C1orf198 | chromosome 1 open reading frame 198 | 1q42.2 | 0.313 | -0.405 | 0
|
GSDMD | gasdermin D | 8q24.3 | 0.311 | 0.364 | 1e-14
|
PSMD1 | proteasome 26S subunit, non-ATPase 1 | 2q37.1 | 0.31 | 0.437 | 0
|
FLJ37453 | | | 0.305 | -0.487 | 0
|
KIAA0040 | KIAA0040 | 1q25.1 | 0.304 | 0.492 | 0
|
DBNL | drebrin-like | 7p13 | 0.304 | 0.448 | 0
|
CASKIN1 | CASK interacting protein 1 | 16p13.3 | 0.303 | -0.525 | 0
|
GLS2 | glutaminase 2 (liver, mitochondrial) | 12q13 | 0.303 | -0.458 | 0
|
SH3TC1 | SH3 domain and tetratricopeptide repeats 1 | 4p16.1 | 0.303 | 0.359 | 2.79e-14
|
ACVR2B-AS1 | ACVR2B antisense RNA 1 | 3p22.2 | 0.301 | -0.489 | 0
|
RIMKLA | ribosomal modification protein rimK-like family member A | 1p34.2 | 0.3 | -0.485 | 0
|
PSMA6 | proteasome subunit alpha 6 | 14q13 | 0.3 | 0.37 | 2.8e-15
|
ZNF77 | zinc finger protein 77 | 19p13.3 | 0.299 | -0.442 | 0
|
ARPC2 | actin related protein 2/3 complex, subunit 2, 34kDa | 2q36.1 | 0.299 | 0.467 | 0
|
RALB | v-ral simian leukemia viral oncogene homolog B | 2q14.2 | 0.296 | 0.467 | 0
|
AOC2 | amine oxidase, copper containing 2 (retina-specific) | 17q21 | 0.294 | -0.445 | 0
|
LIPA | lipase A, lysosomal acid, cholesterol esterase | 10q23.2-q23.3 | 0.291 | 0.444 | 0
|
CACNA2D2 | calcium channel, voltage-dependent, alpha 2/delta subunit 2 | 3p21.3 | 0.29 | -0.455 | 0
|
EIF4E2 | eukaryotic translation initiation factor 4E family member 2 | 2q37.1 | 0.289 | 0.392 | 0
|
MAN2A2 | mannosidase, alpha, class 2A, member 2 | 15q25 | 0.288 | -0.428 | 0
|
CSRP1 | cysteine and glycine-rich protein 1 | 1q32 | 0.288 | 0.292 | 8.7e-10
|
LGALS9C | lectin, galactoside-binding, soluble, 9C | 17p11.2 | 0.286 | 0.524 | 0
|
NABP1 | nucleic acid binding protein 1 | 2q32.3 | 0.284 | 0.468 | 0
|
PPM1K | protein phosphatase, Mg2+/Mn2+ dependent, 1K | 4q22.1 | 0.279 | 0.43 | 0
|
HYKK | hydroxylysine kinase | 15q25.1 | 0.278 | -0.36 | 2.03e-14
|
FAM3D | family with sequence similarity 3, member D | 3p21.1 | 0.277 | -0.262 | 4.23e-08
|
AMPD3 | adenosine monophosphate deaminase 3 | 11p15 | 0.275 | 0.425 | 0
|
MRPL34 | mitochondrial ribosomal protein L34 | 19p13.1 | 0.274 | -0.346 | 2.36e-13
|
DUSP22 | dual specificity phosphatase 22 | 6p25.3 | 0.272 | 0.371 | 2.47e-15
|
PLAC8 | placenta-specific 8 | 4q21.22 | 0.271 | 0.369 | 3.64e-15
|
HDLBP | high density lipoprotein binding protein | 2q37.3 | 0.27 | 0.32 | 1.57e-11
|
SMARCAL1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 | 2q35 | 0.27 | 0.426 | 0
|
ASB1 | ankyrin repeat and SOCS box containing 1 | 2q37 | 0.269 | 0.319 | 1.96e-11
|
C17orf58 | chromosome 17 open reading frame 58 | 17q24.2 | 0.267 | -0.462 | 0
|
WSB2 | WD repeat and SOCS box containing 2 | 12q24.23 | 0.267 | -0.319 | 1.82e-11
|
MAX | MYC associated factor X | 14q23 | 0.266 | 0.401 | 0
|
CCNYL1 | cyclin Y-like 1 | 2q33.3 | 0.264 | 0.339 | 7.86e-13
|
PARPBP | PARP1 binding protein | 12q23.2 | 0.263 | -0.31 | 7.53e-11
|
LYPD5 | LY6/PLAUR domain containing 5 | 19q13.31 | 0.263 | 0.416 | 0
|
MMP1 | matrix metallopeptidase 1 | 11q22.2 | 0.258 | 0.383 | 8.61e-17
|
TMEM92 | transmembrane protein 92 | 17q21.33 | 0.257 | 0.374 | 1.13e-15
|
LPPR2 | phospholipid phosphatase related 2 | 19p13.2 | 0.254 | -0.237 | 7.49e-07
|
MYOM3 | myomesin 3 | 1p36 | 0.25 | 0.288 | 1.54e-09
|
PTK2B | protein tyrosine kinase 2 beta | 8p21.1 | 0.247 | 0.373 | 1.59e-15
|
SLC25A28 | solute carrier family 25 (mitochondrial iron transporter), member 28 | 10q24.2 | 0.246 | 0.34 | 6.86e-13
|
MTERF4 | mitochondrial transcription termination factor 4 | 2q37.3 | 0.245 | 0.322 | 1.2e-11
|
MITD1 | MIT, microtubule interacting and transport, domain containing 1 | 2q11.2 | 0.244 | 0.349 | 1.63e-13
|
MR1 | major histocompatibility complex, class I-related | 1q25.3 | 0.244 | 0.294 | 6.78e-10
|
LOC100133669 | | | 0.244 | 0.431 | 0
|
REN | renin | 1q32 | 0.244 | -0.132 | 0.0064
|
FANCD2 | Fanconi anemia, complementation group D2 | 3p25.3 | 0.236 | -0.319 | 1.91e-11
|
GRN | granulin | 17q21.32 | 0.235 | 0.328 | 4.5e-12
|
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 2q35 | 0.235 | 0.342 | 5.07e-13
|
UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2q14.3 | 0.234 | 0.172 | 0.000364
|
ATP6V1E2 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2 | 2p21 | 0.232 | -0.308 | 9.61e-11
|
IFT81 | intraflagellar transport 81 | 12q24.13 | 0.228 | -0.35 | 1.31e-13
|
DNAJC2 | DnaJ (Hsp40) homolog, subfamily C, member 2 | 7q22-q32 | 0.215 | -0.16 | 0.000923
|
NT5C3A | 5'-nucleotidase, cytosolic IIIA | 7p14.3 | 0.211 | 0.188 | 9.79e-05
|